Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

58.33
+0.66001.14%
Volume:1.77M
Turnover:102.70M
Market Cap:14.45B
PE:18.34
High:58.36
Open:57.60
Low:56.95
Close:57.67
52wk High:59.72
52wk Low:33.76
Shares:247.78M
Float Shares:214.00M
Volume Ratio:0.77
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.18
EPS(LYR):2.78
ROE:44.39%
ROA:23.97%
PB:7.84
PE(LYR):20.98

Loading ...

Adagene Receives Milestone Payment From Exelixis

MT Newswires Live
·
Yesterday

Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration

TIPRANKS
·
Yesterday

Adagene Receives USD 2 Million Exelixis Milestone Payment for SAFEbody ADC Program

Reuters
·
Yesterday

Adagene Hits Preclinical Milestone for Exelixis-Partnered XB404 SAFEbody ADC, Triggers $2 Million Payment

Reuters
·
Yesterday

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

GlobeNewswire
·
Yesterday

EXEL Industries Updates Share Capital and Voting Rights for August 2026

TIPRANKS
·
Sep 03

Exelixis to Webcast Fireside Chats at Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Exelixis Secures Key Patent Victory, Extends Exclusivity

TIPRANKS
·
Sep 01

Exelixis Wins Appeal in Patent Case Against MSN Laboratories

MT Newswires Live
·
Sep 01

Exelixis says appeals court affirmed ‘key portion’ of 2024 judgment

TIPRANKS
·
Sep 01

Exelixis Wins Federal Circuit Ruling Upholding Cabometyx Crystalline Salt Patents

Reuters
·
Sep 01

Exelixis - U.S. Court of Appeals for the Federal Circuit Affirms Key Portion of 2024 Judgment in Exelixis' Favor

THOMSON REUTERS
·
Sep 01

Exelixis Announces Update on Patent Litigation Trial Appeal with Msn Laboratories

THOMSON REUTERS
·
Sep 01

Exelixis - Msn May Launch Generic Cabozantinib in U.S. no Earlier than January 15, 2030

THOMSON REUTERS
·
Sep 01

13D Filings

Dow Jones
·
Aug 22

EXEL INDUSTRIES Updates Market on Share Capital and Voting Rights

TIPRANKS
·
Aug 20

BMO starts Exelixis at Market Perform into patent cliff

TIPRANKS
·
Aug 19

Exelixis Director Mary C Beckerle Disposes of 9,812 Shares Worth $526,908.92

Reuters
·
Aug 13

Exelixis (EXEL) Earnings Strength Meets Lower Guidance As Valuation Comes Back Into View

Simply Wall St.
·
Aug 12

Exelixis Earnings Call: Cabo Strength, Zanza Awaited

TIPRANKS
·
Aug 08